Cancer Treatment and Medical Negligence in Turkey: Compensation Claims

Cancer malpractice cases are among the most medically and legally complex forms of healthcare litigation.

Unlike many surgical malpractice disputes, the central question is not always whether a doctor physically injured the patient during an operation.

The alleged negligence may instead concern time.

A doctor may fail to recognise signs of cancer.

A pathology laboratory may classify malignant tissue as benign.

A radiological finding may not be followed up.

A patient may be incorrectly told that a pathology result is clear.

A necessary oncology referral may be delayed.

Chemotherapy or radiotherapy may begin months later than it should have.

In another category of case, the opposite occurs: a patient who does not have cancer may be wrongly diagnosed with malignancy and subjected to radical surgery, organ removal or toxic treatment that was medically unnecessary.

These scenarios can have dramatically different legal consequences, but they share one feature:

the quality and timing of cancer diagnosis and treatment can materially affect a patient’s life, bodily integrity and treatment options.

Turkish law recognises a patient’s right to diagnosis, treatment and care that comply with contemporary medical knowledge and technology. Article 11 of the Patient Rights Regulation states that patients have the right to diagnosis, treatment and care in accordance with modern medical knowledge and technology, while Article 14 requires healthcare personnel to exercise the medical care required by the patient’s condition.

That does not mean every late cancer diagnosis constitutes malpractice.

Cancer can be difficult to diagnose.

Pathological appearances may be ambiguous.

Some tumours develop rapidly.

Some cancers are already advanced when first clinically detectable.

And even an earlier diagnosis may, in some patients, have resulted in exactly the same treatment and prognosis.

Turkish courts therefore do not normally decide cancer malpractice cases by asking only:

“Was cancer diagnosed late?”

They ask:

Should it reasonably have been diagnosed earlier?

Did the healthcare provider depart from accepted medical standards?

Did the delay change treatment, prognosis or the patient’s condition?

Was the patient exposed to unnecessary treatment because of a wrong diagnosis?

Did the patient suffer independently compensable distress or bodily harm?

Recent Court of Cassation and Council of State decisions provide particularly useful guidance on these issues.

What Can Constitute Cancer Medical Negligence in Turkey?

Cancer-related malpractice can arise at several different stages of the healthcare process.

The most common categories include delayed diagnosis, incorrect diagnosis, pathology error, failure to order necessary tests, failure to act on abnormal results, inadequate oncology referral, inappropriate treatment and deficient informed consent.

A cancer case should therefore be analysed from the patient’s first relevant medical presentation, not only from the day cancer was finally diagnosed.

For example, a patient may first attend hospital because of unexplained bleeding.

Another may present with a breast lump.

Another may have persistent tongue ulceration, unexplained weight loss, blood in the urine, abnormal prostate findings or suspicious imaging.

The legal question becomes whether a reasonably careful healthcare professional should have investigated those findings differently.

Delayed Cancer Diagnosis Does Not Automatically Mean Malpractice

A delayed diagnosis is not automatically negligent.

The law does not require doctors to diagnose every cancer immediately regardless of the clinical evidence available.

The correct question is whether the healthcare professional’s conduct fell below the standard of care reasonably expected in the circumstances.

This distinction appears clearly in a 16 April 2025 Court of Cassation decision, 3rd Civil Chamber E. 2024/2647, K. 2025/2208.

The patient had undergone surgery following post-menopausal abnormal bleeding. The original pathology assessment suggested a low probability of malignancy. Approximately six months later, metastatic leiomyosarcoma was diagnosed elsewhere.

The claimant argued that the cancer had been detected too late and that the opportunity for earlier treatment had been lost.

However, Adli Tıp and university expert reports found the original diagnostic and treatment process compatible with medical standards. The Court of Cassation relied on the mutually supportive, reviewable expert reports and upheld dismissal of the malpractice claim.

This decision is important because it demonstrates that:

later discovery of advanced cancer does not itself prove that the earlier medical assessment was negligent.

The medical records must show that the provider actually missed something that reasonably should have been recognised.

But Delayed Diagnosis Can Constitute Medical Negligence

The opposite conclusion is possible where evidence shows that the doctor failed to perform appropriate diagnostic steps or mishandled the available results.

A particularly useful example is Yargıtay 3rd Civil Chamber E. 2022/7190, K. 2023/2147, dated 12 July 2023.

The patient had prostate-related symptoms.

The expert evidence identified several serious deficiencies. Necessary PSA testing was not performed at the relevant stage, rectal examination was either not performed or not properly recorded, and a pathology report was allegedly confused with that of another patient with a similar name. Tissue obtained during a later operation was also not sent for pathological examination.

As a result, the patient’s prostate cancer treatment began approximately ten months later than it otherwise might have.

The medical experts could not conclusively determine whether the delay actually changed the clinical course of the cancer, and they noted that the treatment protocol would have been the same even with earlier diagnosis.

Nevertheless, they concluded that the physician had failed to exercise the required professional care and that the diagnostic and treatment delay was medically inappropriate. The Court ultimately upheld an award of 75,000 TL in non-pecuniary damages, while the material-damages claim was rejected because the claimant had not adequately proved the claimed financial losses.

This case contains several important lessons for cancer malpractice claims.

First, negligence and causation are separate questions.

Second, deficient diagnosis and record keeping can themselves become legally significant.

Third, even where experts cannot establish that the delayed diagnosis actually altered the cancer treatment, the negligent process and resulting distress may still support a non-material compensation claim in the particular circumstances.

Pathology Errors Are Especially Important in Cancer Cases

Cancer treatment frequently depends on pathology.

A pathology report may determine:

whether a tumour is benign or malignant,

the type of cancer,

its biological characteristics,

and the appropriate treatment strategy.

An error at this stage can lead to two opposite forms of harm.

A false negative can delay cancer treatment.

A false positive can cause a patient without cancer to undergo unnecessary surgery or treatment.

Both can potentially constitute serious medical negligence.

Wrong Cancer Diagnosis Leading to Unnecessary Breast Removal

A major recent decision illustrates how serious a pathology error can become.

In Danıştay 10th Chamber E. 2022/3623, K. 2025/4890, dated 28 October 2025, the patient was diagnosed with invasive breast cancer after pathological examination.

Based on that diagnosis, she underwent a skin-sparing mastectomy, removal of sentinel/axillary lymphatic tissue and implant reconstruction.

Subsequent examination of the pathology materials at other medical institutions concluded that there was no invasive or in-situ carcinoma. The relevant pathological findings were instead compatible with other breast lesions.

The Adli Tıp report concluded that the pathological conduct leading to the mistaken diagnosis was not consistent with medical rules. The administrative courts found service fault on the part of the public healthcare system.

The consequences were profound.

The patient had lost her right breast and a substantial portion of her axillary lymphatic tissue because of an erroneous cancer diagnosis.

Danıştay upheld the material compensation aspect of the decision and concluded that the 20,000 TL moral compensation awarded by the appellate administrative court was disproportionately low given the organ loss and severity of the service fault. It held that the claimant’s requested 200,000 TL moral damages should be fully compensated and reversed that part of the appellate judgment.

The exact historical compensation figures in that case should not be treated as a current tariff for cancer malpractice.

But the legal principle is extremely important:

a false cancer diagnosis that leads to unnecessary organ removal can constitute a very serious healthcare service fault and justify substantial non-material compensation.

False Positive and False Negative Cancer Diagnoses Are Legally Different

Cancer misdiagnosis claims should therefore be divided into two broad categories.

A false-negative diagnosis involves cancer being missed or wrongly characterised as benign.

The principal alleged harm may be:

delayed treatment,

disease progression,

loss of treatment options,

additional surgery,

or reduced survival prospects.

A false-positive diagnosis means the patient is incorrectly told that cancer exists when it does not.

The resulting injury can include:

unnecessary mastectomy,

organ removal,

chemotherapy,

radiotherapy,

fertility damage,

psychological trauma,

or other invasive treatment that was never medically required.

The evidence and causation analysis will differ substantially between these two categories.

Failure to Order Necessary Tests

A cancer diagnosis may be delayed not because an existing test was misread but because an appropriate test was never ordered.

The prostate cancer decision discussed above provides a strong example.

Experts criticised the failure to obtain appropriate PSA testing and examination and also noted deficiencies in pathology handling and medical records.

Depending on the cancer and symptoms, a malpractice inquiry may examine whether accepted medical practice required:

imaging,

biopsy,

tumour-marker testing,

endoscopy,

repeat pathology,

specialist consultation,

or another diagnostic step.

Whether a particular test was medically required cannot be decided in the abstract.

It normally requires specialist evidence based on the patient’s symptoms and knowledge available at that time.

Failure to Follow Up an Abnormal Result

Cancer negligence can also arise when the correct test is performed but nobody acts on the result.

For example, a pathology report may recommend further evaluation.

An imaging report may identify a suspicious lesion.

A laboratory result may require repeat assessment.

A physician may receive the information but fail to communicate it to the patient or arrange appropriate follow-up.

In such a case, the central negligence may not concern diagnosis itself.

It may concern failure to act on available diagnostic information.

Accurate medical records and communication logs can become crucial evidence.

Medical Records Are Particularly Important in Oncology Claims

Article 16 of the Patient Rights Regulation gives the patient the right to inspect the medical file and obtain copies directly or through a lawyer or legal representative. Article 17 also allows correction and completion of incomplete, unclear or erroneous medical and personal records.

For a cancer negligence investigation, the relevant file may include pathology reports, pathology slides and blocks, radiology reports and images, laboratory tests, oncology consultation notes, multidisciplinary tumour-board records, operative reports, chemotherapy protocols, radiotherapy plans and discharge records.

Foreign patients should request these materials as early as possible.

This is particularly important before beginning treatment elsewhere, because a second institution may need the original pathology material to review the diagnosis.

Why Pathology Slides and Blocks Can Be Crucial

In suspected cancer misdiagnosis, obtaining only the written pathology report may not be enough.

A second pathology specialist may need to re-examine:

the original slides,

paraffin blocks,

and immunohistochemical material.

The 2025 Danıştay breast cancer case itself demonstrates the importance of re-evaluation of previous pathology materials. The original diagnosis of invasive carcinoma was reconsidered after the blocks and preparations were examined at other centres.

Therefore, a patient who doubts a cancer diagnosis should consider obtaining an independent pathology review before irreversible treatment where medically appropriate and time permits.

The Right to a Second Medical Opinion

Turkish patient-rights rules expressly recognise the patient’s right to seek another physician’s opinion regarding the same health complaint.

Article 18 also requires medical information to be communicated in an understandable way and generally by the healthcare professional responsible for the intervention.

For cancer patients, a second opinion can be particularly valuable before:

radical surgery,

organ removal,

high-risk chemotherapy,

or another irreversible procedure.

This does not mean a doctor is negligent merely because another oncologist later prefers a different treatment strategy.

Medicine can permit more than one acceptable approach.

The relevant question remains whether the original approach fell outside professionally acceptable standards.

Cancer Treatment Errors After Diagnosis

Not every oncology malpractice case concerns delayed diagnosis.

A correct cancer diagnosis can be followed by negligent treatment.

Potential allegations may involve inappropriate surgery, incorrect chemotherapy administration, radiotherapy errors, medication mistakes, failure to monitor dangerous treatment toxicity, or delayed response to treatment complications.

The fact that cancer itself is serious does not reduce the doctor’s duty of care.

A provider cannot attribute every subsequent injury to the underlying cancer where evidence shows that the treatment process caused a separate preventable injury.

Chemotherapy Errors

Chemotherapy can involve highly potent drugs with significant adverse effects.

A malpractice claim may arise where evidence establishes a clinically unacceptable error such as administration inconsistent with the prescribed protocol or failure to respond appropriately to serious treatment toxicity.

However, many chemotherapy side effects are known consequences of appropriate treatment.

Hair loss, nausea, immunosuppression or other recognised toxic effects do not by themselves establish malpractice.

The correct legal question is whether:

the treatment was medically justified,

the drug and dose were appropriately selected,

monitoring was adequate,

and serious adverse events were managed according to accepted oncology standards.

Radiotherapy Errors

Radiotherapy similarly involves expected risks and side effects.

Liability would generally require proof of a negligent departure from the required treatment standard rather than the mere existence of radiation-related injury.

A serious dispute may require examination of:

the treatment plan,

target field,

dose,

fractionation,

quality-control records,

and subsequent injury.

Because these issues are highly technical, the correct expert specialisation is critical.

Cancer Surgery and Unnecessary Organ Removal

Oncological surgery can legitimately involve radical intervention.

A mastectomy, bowel resection, prostate procedure or other organ removal is not malpractice merely because it is severe.

The issue is whether the procedure was medically justified based on a reliable diagnosis and accepted treatment standards.

The 2025 Danıştay decision demonstrates the legal consequences when the foundation for radical surgery—the cancer diagnosis itself—is wrong.

This type of case requires careful distinction between:

a medically necessary radical cancer operation,

and

an unnecessary operation produced by negligent diagnosis.

Does a Delayed Cancer Diagnosis Have to Change the Final Outcome?

This is one of the hardest questions in oncology malpractice.

A doctor may clearly have acted negligently, but compensation for progression or death still requires analysis of causation.

Suppose cancer should have been diagnosed six months earlier.

Would earlier treatment probably have:

prevented metastasis,

allowed less extensive surgery,

increased survival,

or avoided another specific injury?

If the answer cannot be established medically, certain material damages may be difficult to recover.

The Court of Cassation’s prostate cancer decision illustrates this problem.

Experts found the physician negligent and confirmed approximately ten months of diagnostic delay, but they could not determine whether that delay altered the disease’s clinical course. Material damages were rejected for lack of proof, while moral compensation remained recoverable in that case.

“Loss of Chance” in Cancer Malpractice Claims

Foreign patients sometimes describe delayed diagnosis as a loss of survival chance.

This concept should be used carefully in Turkish litigation.

There is no simple rule that every statistical reduction in the probability of recovery automatically produces a separate fixed award.

Turkish courts generally require rigorous examination of fault, causation and legally established damage.

A useful Danıştay precedent demonstrates the correct evidentiary approach.

In Danıştay 10th Chamber E. 2019/6669, K. 2021/5461, a patient with a persistent tongue lesion was eventually diagnosed with cancer and later died.

The court criticised reliance on an expert panel that did not contain specialists from surgical oncology, radiation oncology or medical oncology.

Danıştay stated that an appropriate specialist panel should examine the correct medical approach and, importantly, whether the patient would have had a possibility of survival if medically appropriate treatment had been provided.

For cancer cases, this is highly significant.

The patient’s lawyer should not simply make an abstract argument that “earlier diagnosis is always better.”

The case should obtain specialist evidence addressing the patient’s actual tumour type, stage, treatment possibilities and probable consequences of the delay.

The Correct Experts Matter

Oncology litigation requires specialised medical knowledge.

The specialist who should assess the case depends on the allegation.

A pathology dispute may require an experienced pathologist.

A delayed breast cancer case may require breast surgery and medical oncology specialists.

A radiotherapy dispute may require radiation oncology expertise.

A chemotherapy dispute may require medical oncology.

A cancer surgery dispute may require surgical oncology or the relevant organ-specific surgical specialty.

The Danıştay tongue cancer case expressly rejected an expert analysis that did not include relevant oncology disciplines and required a new assessment by a properly constituted specialist panel.

This principle applies equally to private-hospital litigation.

An expert report should not merely be formally complete.

It must contain specialists capable of answering the medical questions actually in dispute.

A Negative Expert Report Does Not Always End the Case

A claimant should examine whether the expert report answers the specific allegations.

For example, does the report explain:

why the suspicious lesion did not require biopsy?

why pathology did not require a second review?

whether the delay changed staging?

whether earlier treatment could have been less invasive?

whether oncology referral was timely?

whether the patient was properly informed?

If the report says only:

“Cancer can develop rapidly and treatment was appropriate,”

without addressing the patient’s specific chronology, the report may not provide a sufficient basis for judgment.

Recent Turkish appellate jurisprudence repeatedly emphasises that medical expert evidence must be detailed, reviewable and responsive to the allegations.

Informed Consent in Cancer Treatment

Cancer treatment often requires difficult decisions involving surgery, chemotherapy and radiotherapy.

The Patient Rights Regulation requires the patient to be informed about the likely causes and course of the disease, the intervention, alternatives and their benefits and risks, possible complications, important characteristics of medications and the consequences of declining treatment.

The information must be provided in a way the patient can understand, and outside emergencies the patient should generally be given reasonable time to consider it. The Regulation also recognises the patient’s right to seek a second opinion.

This can be particularly important where the proposed cancer treatment is irreversible.

Foreign Cancer Patients and Language Barriers

A foreign patient may receive treatment in Turkey without speaking Turkish.

Cancer treatment can involve extraordinarily complex decisions.

A patient needs to understand, for example:

why surgery is recommended,

whether chemotherapy is neoadjuvant or adjuvant,

what alternatives exist,

what important complications may occur,

and what happens if treatment is refused.

Article 18 requires understandable communication and recognises the use of appropriate communication measures, while the International Health Tourism Regulation creates a specific regulatory framework for patients travelling to Turkey for healthcare and the facilities and intermediaries serving them.

A signature on a Turkish-language form should therefore not automatically be equated with meaningful understanding in every foreign-patient case.

International Cancer Treatment in Turkey

The International Health Tourism and Tourist Health Regulation published on 26 April 2025 applies to persons travelling from abroad to Turkey for healthcare and to the public, university and private healthcare institutions and intermediary organisations serving those patients.

For an international oncology patient, the healthcare provider should therefore be identified carefully.

A foreign patient may communicate with one medical tourism company while actual treatment is carried out by a different hospital.

The patient’s legal file should identify who made the medical decisions, who provided the treatment and which entity issued invoices and medical records.

An intermediary organising travel is not automatically the same legal actor as the oncologist or hospital.

Private Hospital Cancer Malpractice Claims

Treatment supplied by a private hospital or private physician to an individual patient will commonly involve a private-law healthcare relationship.

Turkish Court of Cassation jurisprudence generally characterises ordinary therapeutic medical treatment as a mandate-type relationship, requiring loyalty and a high standard of professional care.

The prostate cancer case provides a direct example: the Court treated the defendant physician as a mandatary, stressed the duty of care and upheld liability for deficiencies that caused diagnostic and treatment delay.

Private healthcare disputes of this kind frequently proceed within the consumer-court framework.

For consumer disputes falling outside the Consumer Arbitration Committee monetary jurisdiction, mandatory mediation generally precedes Consumer Court litigation. Article 73/A of Consumer Protection Law makes mediation a condition of action for Consumer Court disputes, subject to statutory exceptions.

For 2026, the official Consumer Arbitration Committee threshold is 186,000 TL. Disputes below that amount fall within the committee system; disputes at or above it generally proceed through mandatory mediation and then Consumer Court where consumer jurisdiction applies.

Serious cancer malpractice claims will frequently exceed that figure, but claim value must always be calculated individually.

Public Hospital Cancer Malpractice Claims

Cancer negligence at a state hospital follows a different procedural route.

The claim will generally concern service fault — hizmet kusuru — of the administration and proceed through a full-remedy action in administrative jurisdiction.

The 2025 Danıştay wrong-cancer-diagnosis mastectomy case is a direct example of this route. The court treated the erroneous diagnostic process as a healthcare public-service fault.

Article 13 of the Administrative Procedure Law requires a person harmed by administrative conduct to make a prior application to the relevant administration within one year from learning of the conduct and in any event within five years from the conduct. If the application is rejected, or there is no response within 30 days, the subsequent judicial filing period applies.

These periods are especially important in cancer disputes because the patient may spend months focused on treatment before seeking legal advice.

How Long Do You Have to Sue a Private Hospital?

Limitation periods in medical malpractice should never be guessed from a general internet summary.

Different legal bases can produce different periods.

For ordinary contractual malpractice claims involving a private doctor or private hospital, a particularly important recent Court of Cassation decision is 3rd Civil Chamber E. 2023/2982, K. 2024/3055, dated 14 October 2024.

The Court expressly held that the doctor/private healthcare relationship was mandate-based and that the specific five-year limitation period under Article 147 applied rather than simply using the general ten-year limitation period.

However, tort, consumer-law or criminal-law-linked limitation rules can raise additional questions in a particular case.

Therefore, a cancer patient should never wait until treatment is completed before checking the applicable deadline.

Material Compensation in Cancer Malpractice Cases

Where negligence and causation are established, Turkish Code of Obligations Article 54 identifies bodily injury losses including treatment expenses, lost earnings, loss or reduction of working capacity and impairment of economic prospects.

In a cancer negligence case, material damages may potentially include medically necessary additional treatment caused by the error, corrective surgery, rehabilitation and provable income losses.

The claimant must establish that these expenses result from the malpractice rather than merely from the underlying cancer.

This distinction can be critical.

If a patient would have required the same chemotherapy even with timely diagnosis, the entire chemotherapy cost cannot automatically be attributed to the diagnostic delay.

The plaintiff should isolate the additional damage caused by negligence.

Can Foreign Treatment Costs Be Claimed?

Potentially.

Suppose a foreign patient receives a wrong diagnosis or negligent cancer treatment in Turkey and then returns home.

The patient may require treatment in London, Berlin, Paris, Amsterdam or another country.

Those records may help establish:

the correct diagnosis,

the consequences of the Turkish error,

and the additional treatment required.

Reasonable and necessary foreign healthcare expenses may potentially form part of a damages claim where causation is established.

The patient should preserve detailed invoices, proof of payment, operative records and specialist reports.

Loss of Earnings and Reduced Working Capacity

Cancer negligence may substantially extend a patient’s treatment and incapacity.

For example, an unnecessary operation based on a false cancer diagnosis may create permanent functional impairment.

A delayed diagnosis may lead to more invasive treatment and longer absence from work if medical causation is established.

Foreign patients should preserve evidence of actual income, including salary records, employment contracts, tax documents or business accounts.

Article 54 specifically recognises lost earnings and losses arising from reduced or lost working capacity.

Non-Pecuniary Damages

Article 56 of the Turkish Code of Obligations allows an appropriate non-material damages award where bodily integrity has been injured. In severe bodily injury or death, close relatives may also qualify for appropriate moral damages.

Cancer malpractice can produce exceptional psychological suffering.

Consider a patient incorrectly told:

“You have cancer and your breast must be removed.”

The patient undergoes mastectomy.

Weeks later, she learns that she never had cancer.

The resulting harm cannot be measured only by hospital bills.

The 2025 Danıştay judgment recognised precisely this dimension when it found that a 20,000 TL moral award was disproportionately low in a case involving unnecessary breast and lymphatic tissue removal caused by erroneous cancer diagnosis.

Death Caused or Accelerated by Cancer Negligence

Fatal oncology malpractice claims require especially rigorous causation evidence.

Cancer itself may be life-threatening.

The family must therefore establish more than the fact that medical negligence occurred before death.

The expert evidence should address whether the negligent delay or treatment:

caused death,

materially accelerated death,

or deprived the patient of an identifiable treatment opportunity relevant to survival.

The Danıştay tongue cancer case is particularly instructive because the Court specifically required oncology specialists to assess whether proper medical conduct would have given the patient a possibility of survival.

Where death-related liability is established, Turkish law may recognise funeral expenses, losses arising from treatment and inability to work before death, loss-of-support damages and appropriate non-material damages for close relatives.

Wrong Cancer Diagnosis Without Cancer

False-positive cancer diagnosis deserves separate emphasis.

A patient’s greatest legal harm may arise not because treatment was delayed but because unnecessary treatment was administered immediately.

Possible consequences include:

organ loss,

loss of fertility,

permanent scarring,

lymphoedema,

medication toxicity,

psychological trauma.

The 2025 Danıştay mastectomy judgment is among the strongest contemporary Turkish examples of this type of negligence.

A patient in this position should preserve the original pathology materials and all subsequent second-opinion reports.

The Role of the Hospital in Cancer Negligence

Cancer malpractice is not always solely the oncologist’s responsibility.

A hospital can potentially bear responsibility for organisational failures involving:

pathology handling,

patient identification,

record keeping,

communication of test results,

referral systems,

or other institutional processes.

The prostate cancer case is an important example.

The medical records and pathology handling were deficient, and the appellate court considered both physician fault and hospital responsibility; the final moral damages award was imposed jointly against the defendants.

A cancer malpractice investigation should therefore identify whether the error arose from:

one doctor’s judgment,

or

the healthcare system surrounding the patient.

Patient Identification Errors Can Be Catastrophic

The prostate cancer case also highlights a risk that is not purely medical.

The claimant alleged that his pathological material or results had been confused with those of another patient with a similar name.

Expert evidence identified errors in pathology-result handling and record keeping.

This type of mistake can result in:

failure to diagnose cancer,

treatment of the wrong patient,

or major delay.

Hospitals must operate reliable systems for identifying patients and matching diagnostic material to the correct medical file.

What Evidence Should a Foreign Cancer Patient Preserve?

Cancer malpractice claims are highly document-dependent. A patient should create one complete evidence file containing, wherever available:

the first consultation records; pathology reports and original pathology material; radiological reports and images; laboratory and tumour-marker results; operative reports; oncology consultations; chemotherapy and radiotherapy protocols; informed-consent forms; hospital discharge records; invoices; correspondence and WhatsApp messages; second-opinion reports; foreign treatment records; and documents proving income loss or additional expenses.

This is the most important practical evidence checklist in the case.

Do not rely only on the final discharge summary.

A Practical Example: Delayed Prostate Cancer Diagnosis

A foreign patient attends a private Turkish hospital with urinary symptoms.

Appropriate diagnostic testing is omitted.

The patient is incorrectly told that pathological findings are clear.

Nine months later another hospital diagnoses prostate cancer.

The legal investigation should ask:

Were accepted diagnostic tests omitted?

Were pathological results mishandled?

Would earlier diagnosis have changed cancer staging or treatment?

Did the delay create a separately compensable psychological or physical injury?

The Court of Cassation prostate cancer decision demonstrates that even where experts cannot establish that the delay changed the disease course, professionally negligent diagnostic delay may still have legal consequences.

Practical Example: Wrong Breast Cancer Diagnosis

A patient undergoes biopsy and is told that invasive breast cancer is present.

A mastectomy and lymph-node procedure are performed.

Subsequent pathology review shows no carcinoma.

This closely resembles the 2025 Danıştay case.

The claim may involve organ loss, treatment costs, additional reconstruction, working-capacity consequences and substantial non-material harm.

Practical Example: Cancer Diagnosed Later but No Malpractice

A patient undergoes surgery.

Pathology identifies a lesion considered unlikely to be malignant under accepted standards.

Six months later metastatic cancer is diagnosed.

Independent Adli Tıp and university experts conclude the earlier pathology and clinical decisions complied with medical science.

The Court of Cassation’s April 2025 leiomyosarcoma decision demonstrates that a later diagnosis of advanced cancer does not automatically transform an earlier medically defensible assessment into malpractice.

Practical Example: Fatal Cancer With Inadequate Expert Evidence

A cancer patient dies after treatment at a public hospital.

An expert panel without medical oncology, radiation oncology or surgical oncology specialists states that treatment was appropriate.

That report may be inadequate where the dispute requires oncology-specific analysis.

Danıştay has expressly required relevant oncology specialists to examine both the appropriate medical approach and whether compliant treatment would have given the patient a possibility of survival.

Frequently Asked Questions

Is delayed cancer diagnosis automatically medical malpractice in Turkey?

No. The patient must generally establish that the healthcare provider failed to act according to accepted medical standards. The 2025 Court of Cassation leiomyosarcoma decision upheld dismissal where expert reports found the earlier diagnostic process medically appropriate despite a later metastatic diagnosis.

Can delayed cancer diagnosis still create liability if the treatment would have been the same?

Potentially. In the 2023 prostate cancer case, experts stated that earlier diagnosis would have led to the same treatment and could not determine whether the delay changed disease progression. Nevertheless, professional negligence and diagnostic delay were established and moral compensation was upheld.

Can I sue if pathology incorrectly says I do not have cancer?

Potentially, where the erroneous pathology was negligent and caused delayed diagnosis or additional harm.

Can I sue if pathology incorrectly says that I do have cancer?

Potentially. The 2025 Danıştay decision involved a patient who underwent mastectomy and lymphatic tissue removal following an erroneous cancer diagnosis; service fault and compensation liability were recognised.

Can a hospital be responsible for mixing up pathology results?

Potentially. Record keeping, pathology handling and patient-identification systems form part of safe healthcare organisation. The Court of Cassation prostate cancer case involved alleged confusion of pathology information between similarly named patients.

Is chemotherapy side-effect automatically malpractice?

No. Many chemotherapy effects are recognised treatment consequences. Liability requires a medically relevant error such as inappropriate treatment, dosing or monitoring, supported by specialist evidence.

Can radiotherapy cause a malpractice claim?

Potentially where treatment planning or delivery negligently departs from accepted standards and causes additional injury. The mere existence of radiation side effects does not prove negligence.

Can unnecessary cancer surgery lead to compensation?

Yes, potentially. The 2025 Danıştay wrong breast cancer diagnosis case is a strong example of compensation arising after unnecessary organ removal.

Do I have a right to a second oncology opinion?

The Patient Rights Regulation recognises the patient’s right to request another physician’s opinion concerning the same medical complaint.

Can I obtain my pathology records from a Turkish hospital?

Yes. Article 16 gives the patient the right to inspect the medical file and obtain copies personally or through an authorised representative.

Does a foreign patient have the same patient rights?

The Patient Rights Regulation applies broadly to persons entitled to receive healthcare in public and private institutions, while the 2025 International Health Tourism Regulation specifically regulates patients travelling from abroad for healthcare.

Which court handles cancer negligence at a private hospital?

Private personal healthcare malpractice commonly proceeds within the consumer/private-law framework. Serious Consumer Court disputes generally require mandatory mediation first where no statutory exception applies.

Which court handles cancer negligence at a state hospital?

Public hospital malpractice generally proceeds through administrative jurisdiction as a full-remedy action against the responsible administration.

What is the deadline for a public hospital claim?

Article 13 of the Administrative Procedure Law generally requires the preliminary administrative application within one year of learning of the administrative conduct and in any event within five years of the conduct.

What is the limitation period for a private hospital malpractice claim?

The precise legal basis must be analysed. In a 2024 medical malpractice decision, the Court of Cassation held that an ordinary mandate-based claim against a private doctor/healthcare provider was subject to the specific five-year period rather than simply the general ten-year period. Other legal bases may create different issues, so individual limitation analysis is essential.

Can I claim treatment costs incurred in my home country?

Potentially, where the foreign treatment was necessary and causally related to the Turkish malpractice and is properly documented.

Can I claim lost salary?

Potentially. Turkish Code of Obligations Article 54 recognises lost earnings and losses arising from reduced or lost working capacity.

Can family members claim if the patient dies?

Potentially. Severe bodily injury and death can support appropriate non-material claims for close relatives under Article 56, while separate death-related economic losses may also arise.

Do I have to return to Turkey to sue?

Not necessarily. A foreign patient can potentially appoint Turkish counsel and have many procedural steps undertaken while remaining abroad.

Conclusion: Cancer Malpractice Claims Depend on Diagnosis, Timing, Causation and Specialist Evidence

Cancer treatment negligence cannot be analysed using the simple rule:

“Cancer was diagnosed late, therefore the doctor is liable.”

Nor can a healthcare provider defend every claim by saying:

“Cancer is a difficult disease, so no one can be responsible.”

Turkish courts require a much more detailed inquiry.

The starting point is the applicable medical standard.

Under the Patient Rights Regulation, patients are entitled to diagnosis, treatment and care consistent with contemporary medical knowledge and technology, and healthcare professionals must exercise the care required by the patient’s condition.

In a delayed diagnosis case, the court should determine:

what information was available at the time,

what a reasonably careful doctor should have done,

which tests or referrals were medically indicated,

and

whether the provider’s omission actually delayed diagnosis.

The Court of Cassation’s 12 July 2023 prostate cancer decision demonstrates how serious seemingly administrative and diagnostic omissions can become.

The patient was not properly investigated, pathology information was mishandled and cancer treatment was delayed for approximately ten months.

Even though experts could not determine whether the delay changed the cancer’s clinical progression, the Court upheld the finding of professional fault and the award of non-material compensation.

By contrast, the 16 April 2025 leiomyosarcoma decision demonstrates the other side of the law.

A cancer diagnosis appearing several months after an earlier pathology assessment did not itself prove negligence.

Because independent expert reports found the earlier diagnosis and treatment medically appropriate, dismissal was upheld.

These two decisions should be read together.

They show that the date on which cancer was finally diagnosed is not enough.

The quality of the earlier medical process must be reconstructed.

Pathology cases demand even greater care.

The 28 October 2025 Danıştay judgment E. 2022/3623, K. 2025/4890 provides one of the clearest recent examples of catastrophic harm caused by incorrect cancer diagnosis.

The patient underwent removal of her right breast and substantial axillary lymphatic tissue after being diagnosed with invasive breast cancer.

Later reviews found no carcinoma.

Adli Tıp identified the relevant pathology conduct as inconsistent with medical rules, the administrative courts recognised service fault and Danıştay held that the reduced moral damages award did not adequately reflect the severity of the resulting organ loss.

The lesson is straightforward:

a false-positive cancer diagnosis can be as legally serious as a missed cancer diagnosis.

One delays necessary treatment.

The other can expose a healthy person to treatment that should never have occurred.

Cancer cases also make causation exceptionally important.

Where delayed diagnosis is alleged to have caused progression, metastasis or death, the court should require specialist evidence addressing the patient’s actual prognosis.

The Danıştay tongue cancer decision is instructive.

The Court rejected an expert assessment lacking relevant oncology specialists and required a panel containing surgical, radiation and medical oncology expertise to determine both the proper treatment approach and whether compliant treatment would have given the patient a possibility of survival.

This is the correct way to approach claims described as “loss of survival chance.”

The argument must be medically grounded.

A general statistical statement that early cancer diagnosis is better is rarely sufficient by itself.

The expert should analyse:

the cancer type,

stage,

biological characteristics,

available treatment,

and probable consequence of the particular delay.

Foreign patients have additional practical considerations.

They may have been diagnosed in Turkey but treated later in another country.

A British oncologist may identify that Turkish pathology was incorrect.

A German surgeon may perform additional surgery because the original cancer operation was unnecessary or incomplete.

A French oncology centre may restage the disease.

These foreign records can become critical Turkish litigation evidence.

The patient should preserve both the Turkish medical file and the complete foreign treatment file.

Medical records should be obtained early.

Article 16 expressly gives patients access to their health files and copies through themselves, a lawyer or legal representative. Article 17 permits patients to seek correction or completion of erroneous or incomplete information.

In suspected pathology error, the patient should also consider preservation of the original pathology material.

A second written report alone may not be enough.

The slides and blocks may permit independent re-examination of the actual tissue that generated the disputed diagnosis.

Foreign patients should also be fully informed about their cancer treatment.

Patient-rights rules require information about diagnosis, the proposed intervention, alternatives, relevant risks and complications, important medication characteristics and the consequences of refusing treatment.

For international patients, understandable communication is particularly important.

Cancer decisions are frequently irreversible.

A person should not undergo mastectomy, major organ surgery or toxic oncology treatment without meaningful information simply because a clinic obtained a signature on a form the patient did not understand.

The procedural route must also be selected correctly.

For private hospitals, the claim commonly proceeds within the private/consumer framework, with mandatory mediation applying before Consumer Court proceedings in cases outside statutory exceptions.

For 2026, the Consumer Arbitration Committee threshold is 186,000 TL, although serious cancer malpractice claims are often substantially above that level.

Public hospital cases follow a different path.

The wrong-diagnosis mastectomy judgment itself was an administrative-law case based on public healthcare service fault.

Article 13 requires strict preliminary application periods, so patients should not delay legal review while focusing exclusively on treatment.

Private malpractice limitation must also be considered early.

Recent Court of Cassation authority confirms that ordinary mandate-based private medical malpractice claims can fall under a five-year specific limitation period, not simply a general ten-year assumption.

Ultimately, a strong cancer malpractice case should answer four questions:

What should the healthcare provider have done?

What did the provider actually do?

How did that failure affect the patient’s diagnosis, treatment or bodily integrity?

What financial and non-financial loss resulted?

If those questions can be supported by medical records and appropriately specialised expert evidence, Turkish law provides mechanisms for seeking compensation.

Foreign patients who suffered delayed cancer diagnosis, incorrect pathology, unnecessary cancer surgery, negligent oncology treatment or another serious cancer-related medical error in Turkey should therefore obtain the complete medical file and independent specialist review as early as possible. In oncology litigation, time is important not only medically but legally: both the disease and the applicable procedural deadlines continue to develop while the patient is deciding what to do.

Legal Disclaimer

This article provides general information concerning cancer treatment negligence and compensation claims under Turkish law as of September 2026. It does not constitute individual legal or medical advice.

Cancer is medically complex, and an adverse outcome, late diagnosis, metastasis or death does not by itself establish medical malpractice.

Liability depends on the patient’s symptoms, cancer type, pathology and radiology findings, accepted medical standards at the relevant time, diagnostic and treatment chronology, informed-consent process, causation and properly specialised expert evidence.

Private and public hospitals are also subject to different procedural routes and limitation rules.

Every cancer malpractice claim should therefore be individually assessed using the complete clinical, pathology, radiology and oncology record.